These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29519208)

  • 21. Brain-derived neurotrophic factor (BDNF) levels in children and adolescents before and after stimulant use a systematic review and metanalysis.
    de Lucca MS; Pimentel MEO; Raimundo CKO; Henriques BD; Moreira TR; Cardoso SA; de Miranda DM
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jul; 125():110761. PubMed ID: 37044279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Benefits and Limitations of Stimulants in Treating ADHD.
    Coghill D
    Curr Top Behav Neurosci; 2022; 57():51-77. PubMed ID: 35503597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder.
    Schrantee A; Bouziane C; Bron EE; Klein S; Bottelier MA; Kooij JJS; Rombouts SARB; Reneman L
    Brain Imaging Behav; 2018 Apr; 12(2):402-410. PubMed ID: 28321605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T; Steeves T
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.
    Eiland LS; Bell EA; Erramouspe J
    Ann Pharmacother; 2014 Oct; 48(10):1350-5. PubMed ID: 24982313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
    Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
    Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A modeled economic evaluation comparing atomoxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United Kingdom.
    Cottrell S; Tilden D; Robinson P; Bae J; Arellano J; Edgell E; Aristides M; Boye KS
    Value Health; 2008; 11(3):376-88. PubMed ID: 18489664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive Deficits Associated With ADHD in Athletes: A Systematic Review.
    Poysophon P; Rao AL
    Sports Health; 2018; 10(4):317-326. PubMed ID: 29337649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.
    Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA
    J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone.
    Spencer TJ; Bhide P; Zhu J; Faraone SV; Fitzgerald M; Yule AM; Uchida M; Spencer AE; Hall AM; Koster AJ; Biederman J
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 28640990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
    Stevenson RD; Wolraich ML
    Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder.
    Reimherr FW; Williams ED; Strong RE; Mestas R; Soni P; Marchant BK
    J Clin Psychiatry; 2007 Jan; 68(1):93-101. PubMed ID: 17284136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attention-Deficit/Hyperactivity Disorder Status and Sex Moderate Mild Traumatic Brain Injury Symptom Severity in Children and Adolescents: Implications for Clinical Management.
    Orban SA; Epstein JN; Carr D; Logan K; Gubanich PJ; Sidol C; Myer GD
    Clin J Sport Med; 2021 Nov; 31(6):e298-e305. PubMed ID: 32058452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.
    Boesen K; Saiz LC; Erviti J; Storebø OJ; Gluud C; Gøtzsche PC; Jørgensen KJ
    Evid Based Med; 2017 Aug; 22(4):143-147. PubMed ID: 28705922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
    Chan E; Fogler JM; Hammerness PG
    JAMA; 2016 May; 315(18):1997-2008. PubMed ID: 27163988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder.
    Jain R; Katic A
    Prim Care Companion CNS Disord; 2016 Aug; 18(4):. PubMed ID: 27828696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines.
    Ramos-Quiroga JA; Montoya A; Kutzelnigg A; Deberdt W; Sobanski E
    Curr Med Res Opin; 2013 Sep; 29(9):1093-104. PubMed ID: 23742051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.